Korro Bio, Inc. (KRRO)

Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	40.22	21.82	55.64	166.15	36.33	83.49
Short-Term Investments	64.78	53.33	70.45	-	18.92	35.04
Cash & Short-Term Investments	104.99	75.16	126.1	166.15	55.25	118.53
Cash Growth	13.53%	-40.40%	-24.11%	200.74%	-53.39%	-
Receivables	-	0.97	1.7	-	-	-
Prepaid Expenses	3.94	5.25	3.74	3.02	1.23	0.64
Restricted Cash	-	1	-	3.56	0.6	0.6
Total Current Assets	108.94	82.37	131.53	172.73	57.08	119.78
Property, Plant & Equipment	14.58	16.22	51.55	42.82	11.89	6.45
Long-Term Investments	19.83	10.03	36.96	-	-	-
Other Long-Term Assets	4.78	4.88	6.2	6.12	4.77	1.35
Total Assets	148.12	113.51	226.24	221.66	73.74	127.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.3	1.65	3.99	7.28	2.61	0.79
Accrued Expenses	5.54	7.61	6.17	9.82	3.18	3.22
Current Portion of Leases	3.07	2.67	1.28	1.99	2.92	-
Current Unearned Revenue	3.01	-	3.51	-	-	-
Other Current Liabilities	-	-	-	0.4	-	0.94
Total Current Liabilities	14.92	11.94	14.96	19.48	8.7	4.95
Long-Term Leases	38.45	40.81	43.48	31.22	0.21	-
Long-Term Unearned Revenue	4.83	7.84	5.91	-	-	-
Other Long-Term Liabilities	1.55	1.48	1.47	1.05	-	0.97
Total Liabilities	59.75	62.07	65.83	51.75	8.91	5.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	-	0.01
Additional Paid-In Capital	540.72	435.06	426.72	352.91	2.81	1.6
Retained Earnings	-439.94	-383.85	-266.59	-183.01	-101.83	-43.8
Comprehensive Income & Other	-0.31	0.21	0.27	-	-0.01	-0.01
Total Common Equity	88.37	51.44	160.42	169.91	-99.03	-42.21
Shareholders' Equity	88.37	51.44	160.42	169.91	64.83	121.66
Total Liabilities & Equity	148.12	113.51	226.24	221.66	73.74	127.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	41.52	43.49	44.77	33.21	3.13	-
Net Cash (Debt)	83.3	41.7	118.29	132.94	52.12	118.53
Net Cash Growth	44.05%	-64.75%	-11.02%	155.08%	-56.03%	-
Net Cash Per Share	5.89	4.44	13.26	86.93	204.24	26.65
Filing Date Shares Outstanding	13.73	14.42	9.39	8.02	5.65	4.45
Total Common Shares Outstanding	13.73	9.42	9.38	8.02	5.4	4.45
Working Capital	94.01	70.44	116.57	153.25	48.38	114.83
Book Value Per Share	6.44	5.46	17.11	21.20	-18.33	-9.49
Tangible Book Value	88.37	51.44	160.42	169.91	-99.03	-42.21
Tangible Book Value Per Share	6.44	5.46	17.11	21.20	-18.33	-9.49
Machinery	9.16	9.05	12.49	11.91	9.13	4.68
Construction In Progress	-	-	0.11	8.24	2.05	0.63
Leasehold Improvements	9.68	9.68	22.44	3.36	2.94	2.88

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error